H
Loading...
Loading...
CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Census population 1,603,797. Pennsylvania Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Philadelphia clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Philadelphia storefront.
Platelet Rich Plasma (PRP) Therapy in Philadelphia, PA for clinics & physicians. PRP therapy systems with… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a Pennsylvania chart is a denial pattern. You are JL. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. Use Pennsylvania Department of Health for community education; use the IFU for the product in the fridge. platelet rich plasma therapy is the SKU conversation, not a patient appointment book.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)Pennsylvania shares JL with DC, DE, MD, NJ. Florida is the only single-state MAC. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. If you also operate in another contractor’s state, say so on the first call — we map both.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES does not publish a city-level diabetes row for Philadelphia. Use the national 12% (CDC National Diabetes Statistics Report) plus your own panel — do not invent a local rate. CDC PLACES does not publish an arthritis rate for Philadelphia. Plan joint volume from your referral mix, not a made-up city figure. Schema on this site does not publish a fabricated star rating for Philadelphia.
CDC PLACES has no incorporated-place row we could match for Philadelphia. We will not interpolate one from the state BRFSS range. Use the national 12% (CDC) plus your panel.
Pennsylvania is in CMS MAC JL, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
The allograft is used to perform the same basic function in the recipient as in the donor (FDA 361). Using umbilical or amniotic tissue as a marketed “stem cell cure” for unrelated conditions is outside that lane and is a Pennsylvania compliance risk.
No. They are B2B distribution pages for licensed providers. Patients in Philadelphia should speak with their clinician, not use a distributor URL as care instructions.
Bring specialty, monthly joint / regenerative volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. PLACES has no city row here; bring your own panel mix. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Philadelphia, PA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Philadelphia is JL geography and published epidemiology — not a street address.
No PLACES city row. National CDC 12% is the floor until you use your own panel.
Pennsylvania Part B wound biologics follow this contractor (siblings: DC, DE, MD, NJ). We train to the articles. We do not write coverage.
City-proper population is scale for a city of 1M+, not a count of orthopedic groups.
No Philadelphia storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.